NCT04842734

Brief Summary

Our aim has been determined to investigate the effect of physical exercise alone and in combination with cognitive exercise, on cognitive, physical function and quality of life in individuals with Alzheimer's Disease during the Covid-19 pandemic period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable alzheimer-disease

Timeline
Completed

Started Apr 2021

Shorter than P25 for not_applicable alzheimer-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 10, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 13, 2021

Completed
14 days until next milestone

Study Start

First participant enrolled

April 27, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 23, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 25, 2021

Completed
Last Updated

July 26, 2022

Status Verified

July 1, 2022

Enrollment Period

3 months

First QC Date

April 10, 2021

Last Update Submit

July 22, 2022

Conditions

Keywords

Alzheimer's diseaseTelerehabilitationPhysical exerciseComputerized Cognitive StimulationCovid-19 PandemicCognitive StimulationOnline physical exerciseAlzheimer disease

Outcome Measures

Primary Outcomes (6)

  • Alzheimer's Disease Related Quality of Life Scale

    This scale evaluates health-related quality of life in individuals with AD. The scale includes 40 questions in total and examines 5 quality of life domains (A-Social Interaction, B-Self Awareness, C-Affect and Mood, D- Enjoying Activities, E-Interaction with the Environment).

    24 weeks

  • Montreal Cognitive Assessment Scale

    MOCA is a short cognitive assessment method developed to detect particularly mild stages of cognitive impairment.

    24 weeks

  • Berg Balance Scale

    Berg Balance Scale measures static and dynamic balance in elderly individuals.

    24 weeks

  • Time up and Go Test

    TUG test evaluates fall risk, mobility and physical performance in the elderly

    24 weeks

  • Sit to Stand Test

    Sit-to-stand test will be performed on an armless chair with a height of 46 cm to determine the physical fitness level of elderly individuals

    24 weeks

  • Arm Curl Test

    The Arm Curl test is one of the subtests of the Senior fitness test and it is performed to evaluate upper extremity muscle strength

    24 weeks

Secondary Outcomes (3)

  • Katz Activities of Daily Living Scale

    24 weeks

  • Lawton Instrumental Activities of Daily Living Scale

    24 weeks

  • Geriatric Depression Scale (Short Form)

    24 weeks

Study Arms (3)

Physical exercise and computerized cognitive stimulation

EXPERIMENTAL

Supervised Physical Exercise Program (SPEP) sessions will be performed simultaneously online together with the physiotherapist and the patient. Participants will be able to do the exercises together with their caregivers if needed. The Computerized Cognitive Stimulation Program (CCSP) (Beynex) will be planned for 12 weeks, 5 days a week, approximately 10 minutes, for a total of 40 sessions. Fisrtly, the use of CCSP will be demonstrated to the patients. Then, it will be given as home program. While the patients play the games in CCSP via their smartphones, their caregivers will be informed in detail about accompanying the patients if they need it. The follow-up of cognitive stimulation will be made with the person accompanying the patient over the phone. Individuals will be evaluated by a physiotherapist who will perform the assessment at pre-treatment, post-treatment (12th week) and follow-up period (24th week).

Other: Physical exercise and computerized cognitive training

physical exercise

EXPERIMENTAL

SPEP sessions will be demonstrated to individuals by a 6-year-experienced physiotherapist via videoconference (Zoom Inc.) and the exercises will be performed simultaneously online together with the physiotherapist and the patient. Participants will be able to do the exercises together with their caregivers if needed. Individuals will be evaluated by a physiotherapist who will perform the assessment at pre-treatment, post-treatment (12th week) and follow-up period (24th week).

Other: Physical exercise

control

NO INTERVENTION

The individuals included in this group will be informed that they should continue their normal daily life activities. Individuals will be evaluated by a physiotherapist who will perform the assessment at pre-treatment, post-treatment (12th week) and follow-up period (24th week).

Interventions

SPEP are planned for 12 weeks, 2 times a week, once a day, 60 minutes / 1 hour

physical exercise

SPEP are planned for 12 weeks, 2 times a week, once a day, 60 minutes / 1 hour. The CCSP is planned for 12 weeks, minimum 3 to maximum 5 days a week, approximately 10 minutes, for a total of 36-60 sessions

Physical exercise and computerized cognitive stimulation

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • ≥ 65 years and older
  • Diagnosed with AD according to DSM-IV diagnostic criteria by a neurologist,
  • MOCA ≥ 13
  • Clinical Dementia Rating Scale \< 2
  • Having sufficient wireless support or telephone connection where the person lives
  • Who gave consent to participate in the study
  • No history of any neurological or orthopedic injury that could prevent participation in the study and affect functional mobility.

You may not qualify if:

  • Geriatric Depression Scale score \> 11
  • Various mobility restrictions, musculoskeletal disorders, (wheelchair use, etc.)
  • Clinically significant aphasia (must be able to understand the therapist's commands)
  • Significant visual or sensory impairment
  • MoCA \< 13
  • Having a severe musculoskeletal disorder
  • Having paralysis
  • Impaired balance
  • The presence of severe lung and heart disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yeditepe University

Istanbul, Eyalet/Yerleşke, 34865, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Alzheimer DiseaseCOVID-19Motor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: It is planned to include 60 individuals diagnosed with AD according to DSM-IV diagnostic criteria by the neurologist. Individuals will be randomly divided into three groups; as the physical exercise group (n=20), physical exercise and cognitive stimulation (n=20) and the control group (n=20) according to inclusion criteria
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

April 10, 2021

First Posted

April 13, 2021

Study Start

April 27, 2021

Primary Completion

July 23, 2021

Study Completion

December 25, 2021

Last Updated

July 26, 2022

Record last verified: 2022-07

Locations